Price defence has always been a consideration for companies but the industry has agreed to reforms that have institutionalised a vast array of powerful new levers that could trigger a profound and enduring shift in its strategic focus.
Do the industry's agreements make the pivot to 'price defence' advocacy permanent?
September 26, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Services Australia reports record number of processed PBS prescriptions
October 21, 2025 - - Latest News -
Endometriosis diagnoses in Australian GP clinics Nearly double over a decade
October 21, 2025 - - Latest News -
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - - Latest News -
Vaccine confidence slips as Australians grow more concerned about access to healthcare
October 20, 2025 - - Latest News -
NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter
October 20, 2025 - - Latest News -
Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies
October 20, 2025 - - Australian Biotech -
Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum
October 20, 2025 - - Australian Biotech